Keyphrases
Indonesia
74%
Thalamotomy
62%
Unified Parkinson's Disease Rating Scale (UPDRS)
56%
Patients with Parkinson's Disease
49%
Parkinson Patients
46%
Surabaya
42%
Scale Validity
37%
Vertebrobasilar Artery
37%
Neurology
37%
Hemifacial Spasm
37%
Parkinsonian Tremor
37%
General Hospital
37%
Questioners
37%
Validation Studies
37%
Reliability Test
37%
Test Validity
37%
Symptom Scale
37%
Mathematical Model
37%
Scale Reliability
37%
Motor Improvement
37%
Caffeine
37%
Double-blind Randomized Controlled Trial
37%
Brain Cells
37%
Rattus Novergicus
37%
Apoptosis-inducing Factor
37%
Plumbum
37%
Apoptosis
37%
Malondialdehyde
37%
Superoxide Dismutase
37%
Ginkgo Biloba
37%
Parkinson's Disease
28%
External Globus Pallidus
25%
Tremor
25%
Ventral Intermediate nucleus of the Thalamus
24%
3T Magnetic Resonance Imaging
24%
Non-motor Symptoms
14%
Indonesian Version
14%
Placebo
14%
Ventral Intermediate nucleus
12%
UPDRS Scores
12%
Atlas-based
12%
Stereotactic Thalamotomy
12%
Cavernoma
12%
Computed Tomography
12%
Decreasing Trend
12%
Neurosurgeon
12%
Disease Severity
12%
Cronbach
9%
Motor Symptoms
9%
Motor Function
9%
Medicine and Dentistry
Parkinson's Disease
100%
Unified Parkinson's Disease Rating Scale
68%
Thalamotomy
62%
Neurology
37%
Hemifacial Spasm
37%
Magnetic Resonance Imaging
37%
Adjuvant
37%
Randomized Controlled Trial
37%
Globus pallidus
25%
Thalamus
21%
Placebo
16%
Mini-Mental State Examination
14%
Cerebellar Artery
12%
Disease Severity
12%
Cavernoma
12%
Computer Assisted Tomography
12%
Stereotypic Movement Disorder
11%
Adverse Event
10%
Motor Performance
10%
English (Language)
7%
Health Care Provider
7%
Quality of Life
7%
Facial Nerve
6%
Digital Subtraction Angiography
6%
Vascular Anomaly
6%
Brainstem
6%
Prevalence
6%
Basal Ganglia
6%
Angiography
6%
Vascular Bundle
6%
Bradykinesia
5%
Adjuvant Therapy
5%
Brain Function
5%
Psychostimulant
5%
Diseases
5%
Adverse Effect
5%